Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects

[Figure: see text] Interleukin 25 (IL-25) is a ligand for IL-25 receptor (IL-25R) with apoptotic effect on breast cancer epithelial cells that are produced by peripheral blood mononuclear cells (PBMCs). In this study, we aimed to evaluate IL-25/IL-25R mRNA expression in PBMCs, and also investigate c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of interferon & cytokine research 2020-03, Vol.40 (3), p.139-144
Hauptverfasser: Barati, Mehdi, Sinaeian, Maryam, Shokrollahi Barough, Mahdieh, Pak, Fatemeh, Semnani, Vahid, Kokhaei, Parviz, Momtazi-Borojeni, Amir Abbas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 144
container_issue 3
container_start_page 139
container_title Journal of interferon & cytokine research
container_volume 40
creator Barati, Mehdi
Sinaeian, Maryam
Shokrollahi Barough, Mahdieh
Pak, Fatemeh
Semnani, Vahid
Kokhaei, Parviz
Momtazi-Borojeni, Amir Abbas
description [Figure: see text] Interleukin 25 (IL-25) is a ligand for IL-25 receptor (IL-25R) with apoptotic effect on breast cancer epithelial cells that are produced by peripheral blood mononuclear cells (PBMCs). In this study, we aimed to evaluate IL-25/IL-25R mRNA expression in PBMCs, and also investigate correlation of IL-25/IL-25R with tumor stages/grades in patients with breast cancer. PBMCs and serum were isolated from 30 patients with breast cancer and 18 normal subjects. ELISA test was conducted for IL-25 cytokine. Total RNA was isolated from 2 × 10 PBMCs and reverse transcribed to cDNA. Quantitative PCRs were performed for IL-25, IL-25R, and GAPDH genes. IL-25 mRNA expression in PBMCs of breast cancer patients (malignant and benign) was significantly lower than that in normal subjects, Also IL-25 expression in breast cancer patients with malignant tumor was significantly lower than that in nonmalignant patients. IL-25R expression in malignant patients was significantly higher than that of benign and normal subjects (  
doi_str_mv 10.1089/jir.2019.0106
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_474495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2366997816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-59553d1eb7aa1f5c7fbf91481c30bd45160329e296fb60758ba48649ebc1e64e3</originalsourceid><addsrcrecordid>eNp1kk1v1DAQhi0Eou3CkSuyxKWXLHb8FR_paoFKBSo-zpbtTES2WTvYCR-_pH8Xh25bqRInj2aed2Y0fhF6Qcmakka_3vVpXROq14QS-QgdUyFUpbgUj0tMlK60JuoIneS8I4TIptZP0RGjmgjC1DG63v60w2ynPgYcO3weJkgDzFd9wLXANrQPU5_BwzjFhLe_xwQ5L8JSuYTUj98h2QGfDTG2-EMMMcx-AJvwBoYhL-3PEtg84Y0NHhK-LGMhTPnfmI8x7Yv4y-x24Kf8DD3p7JDh-eFdoW9vt18376uLT-_ON28uKs-JniqhhWAtBaespZ3wqnOdpryhnhHXckElYbWGWsvOSaJE4yxvJNfgPAXJga1QddM3_4JxdmZM_d6mPyba3hxSVyUCwxXnWhRe_5cfU2zvRbdCyhlpGkUW7emNtoA_ZsiT2ffZl9vYAHHOpmaM17zh5WdW6NUDdBfnFMolCiWl1qqh8n55n2LOCbq7dSgxiztMcYdZ3GEWdxT-5aHr7PbQ3tG3dmB_AQigt4c</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2366997816</pqid></control><display><type>article</type><title>Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects</title><source>Alma/SFX Local Collection</source><creator>Barati, Mehdi ; Sinaeian, Maryam ; Shokrollahi Barough, Mahdieh ; Pak, Fatemeh ; Semnani, Vahid ; Kokhaei, Parviz ; Momtazi-Borojeni, Amir Abbas</creator><creatorcontrib>Barati, Mehdi ; Sinaeian, Maryam ; Shokrollahi Barough, Mahdieh ; Pak, Fatemeh ; Semnani, Vahid ; Kokhaei, Parviz ; Momtazi-Borojeni, Amir Abbas</creatorcontrib><description>[Figure: see text] Interleukin 25 (IL-25) is a ligand for IL-25 receptor (IL-25R) with apoptotic effect on breast cancer epithelial cells that are produced by peripheral blood mononuclear cells (PBMCs). In this study, we aimed to evaluate IL-25/IL-25R mRNA expression in PBMCs, and also investigate correlation of IL-25/IL-25R with tumor stages/grades in patients with breast cancer. PBMCs and serum were isolated from 30 patients with breast cancer and 18 normal subjects. ELISA test was conducted for IL-25 cytokine. Total RNA was isolated from 2 × 10 PBMCs and reverse transcribed to cDNA. Quantitative PCRs were performed for IL-25, IL-25R, and GAPDH genes. IL-25 mRNA expression in PBMCs of breast cancer patients (malignant and benign) was significantly lower than that in normal subjects, Also IL-25 expression in breast cancer patients with malignant tumor was significantly lower than that in nonmalignant patients. IL-25R expression in malignant patients was significantly higher than that of benign and normal subjects (  &lt; 0.05). IL-25 in serum of normal subjects was higher than that of benign and malignant patients. There was a direct association between IL-25R expression and tumor grade/stage of cancer. In conclusion, IL-25 seems as a potential prognostic factor in the serum of breast cancer patients and reduction of IL-25 is associated with a higher grade/stage of cancer.</description><identifier>ISSN: 1079-9907</identifier><identifier>ISSN: 1557-7465</identifier><identifier>EISSN: 1557-7465</identifier><identifier>DOI: 10.1089/jir.2019.0106</identifier><identifier>PMID: 31905037</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Apoptosis ; Benign ; Blood ; Breast cancer ; Color imagery ; Cytokines ; Epithelial cells ; Gene expression ; Glyceraldehyde-3-phosphate dehydrogenase ; Image processing ; Interleukins ; Leukocytes (mononuclear) ; Medicin och hälsovetenskap ; Peripheral blood mononuclear cells ; Tumors</subject><ispartof>Journal of interferon &amp; cytokine research, 2020-03, Vol.40 (3), p.139-144</ispartof><rights>Copyright Mary Ann Liebert, Inc. Mar 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-59553d1eb7aa1f5c7fbf91481c30bd45160329e296fb60758ba48649ebc1e64e3</citedby><cites>FETCH-LOGICAL-c409t-59553d1eb7aa1f5c7fbf91481c30bd45160329e296fb60758ba48649ebc1e64e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31905037$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:143088705$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Barati, Mehdi</creatorcontrib><creatorcontrib>Sinaeian, Maryam</creatorcontrib><creatorcontrib>Shokrollahi Barough, Mahdieh</creatorcontrib><creatorcontrib>Pak, Fatemeh</creatorcontrib><creatorcontrib>Semnani, Vahid</creatorcontrib><creatorcontrib>Kokhaei, Parviz</creatorcontrib><creatorcontrib>Momtazi-Borojeni, Amir Abbas</creatorcontrib><title>Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects</title><title>Journal of interferon &amp; cytokine research</title><addtitle>J Interferon Cytokine Res</addtitle><description>[Figure: see text] Interleukin 25 (IL-25) is a ligand for IL-25 receptor (IL-25R) with apoptotic effect on breast cancer epithelial cells that are produced by peripheral blood mononuclear cells (PBMCs). In this study, we aimed to evaluate IL-25/IL-25R mRNA expression in PBMCs, and also investigate correlation of IL-25/IL-25R with tumor stages/grades in patients with breast cancer. PBMCs and serum were isolated from 30 patients with breast cancer and 18 normal subjects. ELISA test was conducted for IL-25 cytokine. Total RNA was isolated from 2 × 10 PBMCs and reverse transcribed to cDNA. Quantitative PCRs were performed for IL-25, IL-25R, and GAPDH genes. IL-25 mRNA expression in PBMCs of breast cancer patients (malignant and benign) was significantly lower than that in normal subjects, Also IL-25 expression in breast cancer patients with malignant tumor was significantly lower than that in nonmalignant patients. IL-25R expression in malignant patients was significantly higher than that of benign and normal subjects (  &lt; 0.05). IL-25 in serum of normal subjects was higher than that of benign and malignant patients. There was a direct association between IL-25R expression and tumor grade/stage of cancer. In conclusion, IL-25 seems as a potential prognostic factor in the serum of breast cancer patients and reduction of IL-25 is associated with a higher grade/stage of cancer.</description><subject>Apoptosis</subject><subject>Benign</subject><subject>Blood</subject><subject>Breast cancer</subject><subject>Color imagery</subject><subject>Cytokines</subject><subject>Epithelial cells</subject><subject>Gene expression</subject><subject>Glyceraldehyde-3-phosphate dehydrogenase</subject><subject>Image processing</subject><subject>Interleukins</subject><subject>Leukocytes (mononuclear)</subject><subject>Medicin och hälsovetenskap</subject><subject>Peripheral blood mononuclear cells</subject><subject>Tumors</subject><issn>1079-9907</issn><issn>1557-7465</issn><issn>1557-7465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kk1v1DAQhi0Eou3CkSuyxKWXLHb8FR_paoFKBSo-zpbtTES2WTvYCR-_pH8Xh25bqRInj2aed2Y0fhF6Qcmakka_3vVpXROq14QS-QgdUyFUpbgUj0tMlK60JuoIneS8I4TIptZP0RGjmgjC1DG63v60w2ynPgYcO3weJkgDzFd9wLXANrQPU5_BwzjFhLe_xwQ5L8JSuYTUj98h2QGfDTG2-EMMMcx-AJvwBoYhL-3PEtg84Y0NHhK-LGMhTPnfmI8x7Yv4y-x24Kf8DD3p7JDh-eFdoW9vt18376uLT-_ON28uKs-JniqhhWAtBaespZ3wqnOdpryhnhHXckElYbWGWsvOSaJE4yxvJNfgPAXJga1QddM3_4JxdmZM_d6mPyba3hxSVyUCwxXnWhRe_5cfU2zvRbdCyhlpGkUW7emNtoA_ZsiT2ffZl9vYAHHOpmaM17zh5WdW6NUDdBfnFMolCiWl1qqh8n55n2LOCbq7dSgxiztMcYdZ3GEWdxT-5aHr7PbQ3tG3dmB_AQigt4c</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Barati, Mehdi</creator><creator>Sinaeian, Maryam</creator><creator>Shokrollahi Barough, Mahdieh</creator><creator>Pak, Fatemeh</creator><creator>Semnani, Vahid</creator><creator>Kokhaei, Parviz</creator><creator>Momtazi-Borojeni, Amir Abbas</creator><general>Mary Ann Liebert, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20200301</creationdate><title>Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects</title><author>Barati, Mehdi ; Sinaeian, Maryam ; Shokrollahi Barough, Mahdieh ; Pak, Fatemeh ; Semnani, Vahid ; Kokhaei, Parviz ; Momtazi-Borojeni, Amir Abbas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-59553d1eb7aa1f5c7fbf91481c30bd45160329e296fb60758ba48649ebc1e64e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Benign</topic><topic>Blood</topic><topic>Breast cancer</topic><topic>Color imagery</topic><topic>Cytokines</topic><topic>Epithelial cells</topic><topic>Gene expression</topic><topic>Glyceraldehyde-3-phosphate dehydrogenase</topic><topic>Image processing</topic><topic>Interleukins</topic><topic>Leukocytes (mononuclear)</topic><topic>Medicin och hälsovetenskap</topic><topic>Peripheral blood mononuclear cells</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barati, Mehdi</creatorcontrib><creatorcontrib>Sinaeian, Maryam</creatorcontrib><creatorcontrib>Shokrollahi Barough, Mahdieh</creatorcontrib><creatorcontrib>Pak, Fatemeh</creatorcontrib><creatorcontrib>Semnani, Vahid</creatorcontrib><creatorcontrib>Kokhaei, Parviz</creatorcontrib><creatorcontrib>Momtazi-Borojeni, Amir Abbas</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Journal of interferon &amp; cytokine research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barati, Mehdi</au><au>Sinaeian, Maryam</au><au>Shokrollahi Barough, Mahdieh</au><au>Pak, Fatemeh</au><au>Semnani, Vahid</au><au>Kokhaei, Parviz</au><au>Momtazi-Borojeni, Amir Abbas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects</atitle><jtitle>Journal of interferon &amp; cytokine research</jtitle><addtitle>J Interferon Cytokine Res</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>40</volume><issue>3</issue><spage>139</spage><epage>144</epage><pages>139-144</pages><issn>1079-9907</issn><issn>1557-7465</issn><eissn>1557-7465</eissn><abstract>[Figure: see text] Interleukin 25 (IL-25) is a ligand for IL-25 receptor (IL-25R) with apoptotic effect on breast cancer epithelial cells that are produced by peripheral blood mononuclear cells (PBMCs). In this study, we aimed to evaluate IL-25/IL-25R mRNA expression in PBMCs, and also investigate correlation of IL-25/IL-25R with tumor stages/grades in patients with breast cancer. PBMCs and serum were isolated from 30 patients with breast cancer and 18 normal subjects. ELISA test was conducted for IL-25 cytokine. Total RNA was isolated from 2 × 10 PBMCs and reverse transcribed to cDNA. Quantitative PCRs were performed for IL-25, IL-25R, and GAPDH genes. IL-25 mRNA expression in PBMCs of breast cancer patients (malignant and benign) was significantly lower than that in normal subjects, Also IL-25 expression in breast cancer patients with malignant tumor was significantly lower than that in nonmalignant patients. IL-25R expression in malignant patients was significantly higher than that of benign and normal subjects (  &lt; 0.05). IL-25 in serum of normal subjects was higher than that of benign and malignant patients. There was a direct association between IL-25R expression and tumor grade/stage of cancer. In conclusion, IL-25 seems as a potential prognostic factor in the serum of breast cancer patients and reduction of IL-25 is associated with a higher grade/stage of cancer.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>31905037</pmid><doi>10.1089/jir.2019.0106</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1079-9907
ispartof Journal of interferon & cytokine research, 2020-03, Vol.40 (3), p.139-144
issn 1079-9907
1557-7465
1557-7465
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_474495
source Alma/SFX Local Collection
subjects Apoptosis
Benign
Blood
Breast cancer
Color imagery
Cytokines
Epithelial cells
Gene expression
Glyceraldehyde-3-phosphate dehydrogenase
Image processing
Interleukins
Leukocytes (mononuclear)
Medicin och hälsovetenskap
Peripheral blood mononuclear cells
Tumors
title Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T02%3A37%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Interleukin%2025%20and%20Interleukin%2025%20Receptor%20Expression%20in%20Peripheral%20Blood%20Mononuclear%20Cells%20of%20Breast%20Cancer%20Patients%20and%20Normal%20Subjects&rft.jtitle=Journal%20of%20interferon%20&%20cytokine%20research&rft.au=Barati,%20Mehdi&rft.date=2020-03-01&rft.volume=40&rft.issue=3&rft.spage=139&rft.epage=144&rft.pages=139-144&rft.issn=1079-9907&rft.eissn=1557-7465&rft_id=info:doi/10.1089/jir.2019.0106&rft_dat=%3Cproquest_swepu%3E2366997816%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2366997816&rft_id=info:pmid/31905037&rfr_iscdi=true